PAAt a glance
Core facts about the doctor and the hospital, as provided by the hospital.
1 areaSpecialties: Medical Oncology
OncologyCategory
English, TurkishLanguages
JCIAccredited hospital · Ankara
55 staffListed at this hospital
Prof. Deniz Yamac is a Medical Oncologist at Guven Hospital in Ankara, Turkey, a JCI-accredited center. Lists Medical Oncology.
About
She is interested in all types of cancers, particularly breast cancer and head-neck cancer. She also provides training on supportive treatments and communication in cancer.
She has authored many articles in native and foreign languages.
She is engaged in sports and music in her private life. She has also been involved in the studies and the establishment of the "Awareness Chorus" created by women living with breast cancer.
She is married with two sons.
Publications:
➨ 1. Genomic large rearrangement screening of BRCA1 and BRCA2 genes in high-risk Turkish breast/ovarian cancer patients by using multiplex ligation-dependent probe amplification assay. Manguoğlu E, Güran S, Yamaç D, Simşek M, Akdeniz S, Colak T, Gülkesen H, Lüleci G. Cancer Invest. 2011 Jan;29(1):73-7. Epub 2010 Oct 5.
➨ 2. Germline mutations of BRCA1 and BRCA2 genes in Turkish breast, ovarian, and prostate cancer patients. Manguoğlu E, Güran S, Yamaç D, Colak T, Simşek M, Baykara M, Akaydın M, Lüleci G. Cancer Genet Cytogenet. 2010 Dec;203(2):230-7.
➨ 3. Efficacy and toxicity of preoperative chemotherapy with docetaxel and epirubicin in locally advanced invasive breast cancer. Kaya AO, Coskun U, Buyukberber S, Benekli M, Tekin E, Cifter C, Ozturk B, Yildiz R, Yaman E, Uner A, Yamac D. J BUON. 2010 Apr-Jun;15(2):248-54.
➨ Full List of Publications
She has authored many articles in native and foreign languages.
She is engaged in sports and music in her private life. She has also been involved in the studies and the establishment of the "Awareness Chorus" created by women living with breast cancer.
She is married with two sons.
Publications:
➨ 1. Genomic large rearrangement screening of BRCA1 and BRCA2 genes in high-risk Turkish breast/ovarian cancer patients by using multiplex ligation-dependent probe amplification assay. Manguoğlu E, Güran S, Yamaç D, Simşek M, Akdeniz S, Colak T, Gülkesen H, Lüleci G. Cancer Invest. 2011 Jan;29(1):73-7. Epub 2010 Oct 5.
➨ 2. Germline mutations of BRCA1 and BRCA2 genes in Turkish breast, ovarian, and prostate cancer patients. Manguoğlu E, Güran S, Yamaç D, Colak T, Simşek M, Baykara M, Akaydın M, Lüleci G. Cancer Genet Cytogenet. 2010 Dec;203(2):230-7.
➨ 3. Efficacy and toxicity of preoperative chemotherapy with docetaxel and epirubicin in locally advanced invasive breast cancer. Kaya AO, Coskun U, Buyukberber S, Benekli M, Tekin E, Cifter C, Ozturk B, Yildiz R, Yaman E, Uner A, Yamac D. J BUON. 2010 Apr-Jun;15(2):248-54.
➨ Full List of Publications
Education
- She completed secondary and high school educations at TED Ankara College.She graduation from School of medicine of Ankara University, she completed her specialty education and training in Medical oncology and Internal Diseases in School of Medicine, Gazi University.
Professional Experience
- She worked in Cancer center in Arkansas/USA for one year.She worked as a faculty member at the School of Medicine, Gazi University since 1995.In 2011 while she was professor, and she joins the family of Güven Hospital.
Ask the doctor's team about your case
Send your reports and questions to Guven Hospital. The hospital replies through Health-Tourism.com.
Free consultation • No obligation • Direct communication with the hospital
